Meharry Medical College

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Meharry Medical College sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials 2 currently recruiting 5 completed early-phase tilt top decile by trial count

Meharry Medical College: 10 sponsored US clinical trials, 2 recruiting.

Meharry Medical College sponsors 10 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Intimate Partner Violence, with 1 trials.

Top-decile sponsor footprint

Meharry Medical College ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

What is open in the Meharry Medical College pipeline

2 recruiting of 10 indexed (20% open); 5 completed (50%).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Intimate Partner Violence (1 trial), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Meharry Medical College: open-pipeline peers nationwide

Peers matched on 10 registered trials and 20% open enrollment, not the therapeutic-area sidebar.

Meharry Medical College sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 4681012 0%10%20%30%40% Total trials Recruiting share Meharry Medical CollegeAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron PharmaceuticalsAcera SurgicalAlign TechnologyAltruBioAlvernia University
Meharry Medical College sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Meharry Medical College sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 trials (± recruiting share)

Sponsors near 20% open enrollment (± trial volume)

What to do with this Meharry Medical College page

10 registered trials is a research-attention snapshot, not an endorsement of Meharry Medical College or any single study.

  • 2 of Meharry Medical College's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Intimate Partner Violence is the condition Meharry Medical College studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Intimate Partner Violence trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Meharry Medical College pipeline card: 10 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.